Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Omega-3 isn’t just one specific nutrient – it’s the name of a family of fatty acids. The three main omega-3s are ALA, DHA and EPA. ALA is a short-chain fatty acid, while DHA and EPA are long-chain.

You’ve probably heard of omega-3 fatty acids, especially if you have an inflammatory type of arthritis. They help reduce pain and inflammation throughout the body, and some studies have also shown ...